Brief: NuCana Reports Update for Phase 3 Biliary Tract Cancer Study

NuCana

02/03/2022 21:09

March 2 (Reuters) - NuCana PLC  NCNA.O :
    * NUCANA ANNOUNCES UPDATE FOR PHASE 3 BILIARY TRACT CANCER
STUDY
    * NUCANA - INDEPENDENT DATA MONITORING COMMITTEE RECOMMENDED
STUDY
BE DISCONTINUED FOLLOWING FUTILITY ASSESSMENT CONDUCTED AT FIRST
INTERIM ANALYSIS
    * NUCANA PLC - NUC-3373 CONTINUES RAPID DEVELOPMENT WITH
MULTIPLE
DATA READOUTS
    * NUCANA PLC - DOSING OF FIRST PATIENTS IN PHASE 3
COLORECTAL
CANCER STUDY EXPECTED IN 2022
    * NUCANA PLC - NUC-7738 ENTERING PHASE 2 SOLID TUMOR AND
LYMPHOMA
STUDY WITH DATA READOUTS EXPECTED THROUGHOUT 2022

Source text for Eikon:  ID:nGNXb2H3ND 
Further company coverage:  NCNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))